$NCRA
NOCERA, INC. Stock $ncra

$ncra Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000168316823002043 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$5.352K	$9.861M	$16.34M
YoY Change	-99.82%	39.28%	64.29%
Cost Of Revenue	$3.769M	$9.711M	$16.07M
YoY Change	31.62%	49.28%	78.56%
Gross Profit	$68.66K	$149.5K	$267.1K
YoY Change	24.26%	-73.98%	-71.72%
Gross Profit Margin	1282.81%	1.52%	1.63%
Selling, General & Admin	$1.059M	$3.269M	$5.447M
YoY Change	23.04%	-65.98%	-47.72%
% of Gross Profit	1542.97%	2186.46%	2039.46%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$44.73K	$70.82K	$66.91K
YoY Change	5561.77%	5432.81%	991.47%
% of Gross Profit	65.15%	47.37%	25.05%
Operating Expenses	$1.059M	$3.269M	$5.447M
YoY Change	23.04%	-65.98%	-47.72%
Operating Profit	-$990.7K	-$3.119M	-$5.180M
YoY Change	22.96%	-65.48%	-45.33%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$11.51K	$409.9K	$419.8K
YoY Change		-157757.69%	-10440.17%
Pretax Income	-$1.002M	-$2.710M	-$4.760M
YoY Change	24.39%	-70.01%	-49.78%
Income Tax	$0.00	-$23.39K	-$23.81K
% Of Pretax Income
Net Earnings	-$987.6K	-$2.758M	-$4.737M
YoY Change	22.58%	-69.77%	-50.76%
Net Earnings / Revenue	-18453.81%	-27.97%	-28.99%
Basic Earnings Per Share	-$0.11		-$0.61
Diluted Earnings Per Share	-$0.11	-$0.30	-$0.61
COMMON SHARES
Basic Shares Outstanding	9.244M shares		7.876M shares
Diluted Shares Outstanding	9.294M shares		7.876M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.461M	$2.906M	$2.906M
YoY Change	-25.55%	18.91%	18.91%
Cash & Equivalents	$1.461M	$2.906M	$2.906M
Short-Term Investments
Other Short-Term Assets	$202.7K	$1.730K	$1.730K
YoY Change	1031.03%	-95.97%	-95.97%
Inventory	$91.33K	$91.78K	$91.78K
Prepaid Expenses
Receivables	$206.8K	$209.8K	$209.8K
Other Receivables	$7.420K	$27.47K	$27.47K
Total Short-Term Assets	$1.969M	$3.237M	$3.237M
YoY Change	-68.38%	-49.41%	-49.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.686M	$844.6K	$844.6K
YoY Change	2364.12%	1085.5%	1085.42%
Goodwill	$3.906M	$3.906M
YoY Change		1076.28%
Intangibles	$126.4K	$130.4K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.770K	$0.00	$22.70K
YoY Change
Total Long-Term Assets	$5.746M	$4.903M	$4.903M
YoY Change	1181.41%	937.17%	937.18%
TOTAL ASSETS
Total Short-Term Assets	$1.969M	$3.237M	$3.237M
Total Long-Term Assets	$5.746M	$4.903M	$4.903M
Total Assets	$7.715M	$8.140M	$8.140M
YoY Change	15.59%	18.48%	18.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.482K	$2.631K	$2.630K
YoY Change		-84.92%	-84.92%
Accrued Expenses	$870.00	$860.00	$860.00
YoY Change	-97.77%	-99.34%	-99.34%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due	$217.1K	$214.9K	$214.9K
YoY Change
Total Short-Term Liabilities	$1.487M	$1.522M	$1.522M
YoY Change	-24.7%	-27.56%	-27.56%
LONG-TERM LIABILITIES
Long-Term Debt	$400.5K	$436.3K	$436.3K
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$400.5K	$436.3K	$436.3K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.487M	$1.522M	$1.522M
Total Long-Term Liabilities	$400.5K	$436.3K	$436.3K
Total Liabilities	$1.887M	$1.958M	$2.099M
YoY Change	-4.42%	-6.79%	-0.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$15.74M	-$14.75M
YoY Change		48.69%
Common Stock	$9.693K	$9.243K
YoY Change		-12.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.701M	$6.041M	$6.041M
YoY Change
Total Liabilities & Shareholders Equity	$7.715M	$8.140M	$8.140M
YoY Change	15.59%	18.48%	18.48%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$987.6K	-$2.758M	-$4.737M
YoY Change	22.58%	-69.77%	-50.76%
Depreciation, Depletion And Amortization	$44.73K	$70.82K	$66.91K
YoY Change	5561.77%	5432.81%	991.47%
Cash From Operating Activities	-$364.4K	-$1.242M	-$1.911M
YoY Change	-34.14%	-531.02%	-859.14%
INVESTING ACTIVITIES
Capital Expenditures	$857.9K	-$836.4K	$0.00
YoY Change		8363900.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$201.0K	$261.4K	-$4.031M
YoY Change
Cash From Investing Activities	-$1.059M	$1.098M	-$4.031M
YoY Change		-10977600.0%	15978.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$5.666M
YoY Change			135.11%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$41.14K	677.0K	$6.288M
YoY Change	1092.38%	-55.02%	422.37%
NET CHANGE
Cash From Operating Activities	-$364.4K	-1.242M	-$1.911M
Cash From Investing Activities	-$1.059M	1.098M	-$4.031M
Cash From Financing Activities	-$41.14K	677.0K	$6.288M
Net Change In Cash	-$1.446M	532.9K	$462.1K
YoY Change	159.66%	-70.29%	-67.7%
FREE CASH FLOW
Cash From Operating Activities	-$364.4K	-$1.242M	-$1.911M
Capital Expenditures	$857.9K	-$836.4K	$0.00
Free Cash Flow	-$1.222M	-$405.5K	-$1.911M
YoY Change	120.91%	-240.73%	-790.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001756180
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021	NCRA	Cash Disposed Upon Termination Of Vie CashDisposedUponTerminationOfVie		usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	0	usd
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount		usd
CY2022Q4	NCRA	Due From A Related Party DueFromARelatedParty		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41434
CY2022	dei	Entity Registrant Name EntityRegistrantName	NOCERA, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	16-1626611
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	3F (Building B)
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	No. 185
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	Sec. 1
CY2022	NCRA	Entity Address Address Line4 EntityAddressAddressLine4	Datong Rd
CY2022	NCRA	Entity Address Address Line5 EntityAddressAddressLine5	Xizhi Dist.
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New Taipei City
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	221
CY2022	dei	Entity Address Country EntityAddressCountry	TW
CY2022	dei	City Area Code CityAreaCode	886
CY2022	dei	Local Phone Number LocalPhoneNumber	910-163-358
CY2022	dei	Security12b Title Security12bTitle	Common Stock
CY2022	dei	Trading Symbol TradingSymbol	NCRA
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	18658256	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9243587	shares
CY2022	dei	Auditor Firm AuditorFirmId	2769
CY2022	dei	Auditor Name AuditorName	Centurion ZD CPA & Co
CY2022	dei	Auditor Location AuditorLocation	Hong Kong
CY2022	dei	Auditor Firm AuditorFirmId	2769
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2906074	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2444009	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	209777	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	699555	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	91781	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1488681	usd
CY2022Q4	NCRA	Advance To Suppliers AdvanceToSuppliers	1732	usd
CY2021Q4	NCRA	Advance To Suppliers AdvanceToSuppliers	42969	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27470	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	107444	usd
CY2022Q4	NCRA	Due From Related Parties Current1 DueFromRelatedPartiesCurrent1	0	usd
CY2021Q4	NCRA	Due From Related Parties Current1 DueFromRelatedPartiesCurrent1	1615217	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3236834	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	6397875	usd
CY2022Q4	NCRA	Retention Receivables RetentionReceivables	0	usd
CY2021Q4	NCRA	Retention Receivables RetentionReceivables	69489	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	22703	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	844613	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	71245	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	130434	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	3905735	usd
CY2021Q4	us-gaap	Goodwill Goodwill	332040	usd
CY2022Q4	us-gaap	Assets Assets	8140319	usd
CY2021Q4	us-gaap	Assets Assets	6870649	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	92112	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2631	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17442	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	38388	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	142426	usd
CY2022Q4	NCRA	Advance Receipts AdvanceReceipts	42880	usd
CY2021Q4	NCRA	Advance Receipts AdvanceReceipts	1051121	usd
CY2022Q4	NCRA	Due To Related Parties Current1 DueToRelatedPartiesCurrent1	18919	usd
CY2021Q4	NCRA	Due To Related Parties Current1 DueToRelatedPartiesCurrent1	39341	usd
CY2022Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	1179768	usd
CY2021Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	312320	usd
CY2022Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	214913	usd
CY2021Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	0	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	22312	usd
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	6312	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1920	usd
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	387319	usd
CY2022Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	0	usd
CY2021Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	52292	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1521731	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2100685	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	usd
CY2022Q4	NCRA	Longterm Secured Bank Loan LongtermSecuredBankLoan	436341	usd
CY2021Q4	NCRA	Longterm Secured Bank Loan LongtermSecuredBankLoan	0	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1958072	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2100685	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9243587	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7071920	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	9243	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	7071	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	80	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	80	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	20484518	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14476241	usd
CY2022Q4	NCRA	Statutory And Other Reserves StatutoryAndOtherReserves	191219	usd
CY2021Q4	NCRA	Statutory And Other Reserves StatutoryAndOtherReserves	191219	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14747461	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9918553	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	103594	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	13906	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6041193	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4769964	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	141054	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	0	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6182247	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4769964	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8140319	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6870649	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16338754	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9945325	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16071659	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9000733	usd
CY2022	us-gaap	Gross Profit GrossProfit	267095	usd
CY2021	us-gaap	Gross Profit GrossProfit	944592	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5447303	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10419684	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	5447303	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	10419684	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5180208	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-9475092	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	419811	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4055	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4760397	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9479147	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-23808	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	139932	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-4736589	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-9619079	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	76319	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4812908	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9619079	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-4736589	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-9619079	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-89688	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-63676	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4826277	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-9682755	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-76319	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-0	usd
CY2022	NCRA	Less Foreign Currency Translation Loss Attributable To Noncontrolling Interest LessForeignCurrencyTranslationLossAttributableToNoncontrollingInterest	0	usd
CY2021	NCRA	Less Foreign Currency Translation Loss Attributable To Noncontrolling Interest LessForeignCurrencyTranslationLossAttributableToNoncontrollingInterest	0	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4902596	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9682755	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.6111
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.0757
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.6111
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.0757
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7876367	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6107727	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7876367	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6107727	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2550392	usd
CY2021	NCRA	Common Stock And Warrant Issuance CommonStockAndWarrantIssuance	2880	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	29600	usd
CY2021	NCRA	Changes In Fair Value Of Warranty Liabilities ChangesInFairValueOfWarrantyLiabilities	-24800	usd
CY2021	NCRA	Issuance Of New Shares Upon Private Placement IssuanceOfNewSharesUponPrivatePlacement	2090000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3045150	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6638457	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	63676	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	6312	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-9619079	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4769964	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4769964	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4801496	usd
CY2022	NCRA	Purchase Of Noncontrolling Interest PurchaseOfNoncontrollingInterest	64735	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	795500	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	413453	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	89688	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	16000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-4736589	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6182247	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-4736589	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-9619079	usd
CY2022	us-gaap	Depreciation Depreciation	66907	usd
CY2021	us-gaap	Depreciation Depreciation	6127	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4891	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2022	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	-2569975	usd
CY2021	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	-0	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	22703	usd
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-2258	usd
CY2022	NCRA	Change In Fair Value Of Warranty Liabilities ChangeInFairValueOfWarrantyLiabilities	0	usd
CY2021	NCRA	Change In Fair Value Of Warranty Liabilities ChangeInFairValueOfWarrantyLiabilities	24800	usd
CY2022	NCRA	Consultancy Services Settled By Equities ConsultancyServicesSettledByEquities	795500	usd
CY2021	NCRA	Consultancy Services Settled By Equities ConsultancyServicesSettledByEquities	3045150	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	413453	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	6638371	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-89801	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	252338	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1221285	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-278100	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-69229	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-40563	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	384239	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	66232	usd
CY2022	NCRA	Increase Decrease In Retention Receivables IncreaseDecreaseInRetentionReceivables	-67587	usd
CY2021	NCRA	Increase Decrease In Retention Receivables IncreaseDecreaseInRetentionReceivables	-395579	usd
CY2022	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-89591	usd
CY2021	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-99106	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-612494	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	10092	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	96506	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	103599	usd
CY2022	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-342563	usd
CY2021	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	92346	usd
CY2022	NCRA	Increase Decrease In Advance Receipt IncreaseDecreaseInAdvanceReceipt	979474	usd
CY2021	NCRA	Increase Decrease In Advance Receipt IncreaseDecreaseInAdvanceReceipt	267375	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1910977	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	251729	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25067	usd
CY2022	us-gaap	Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates	300082	usd
CY2021	us-gaap	Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates	0	usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	7824	usd
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
CY2022	NCRA	Cash Disposed Upon Termination Of Vie CashDisposedUponTerminationOfVie	46564	usd
CY2022	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	4292176	usd
CY2021	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	-0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4030834	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25067	usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-718341	usd
CY2022	NCRA	Proceeds From Common Stock And Warrant Issuance ProceedsFromCommonStockAndWarrantIssuance	0	usd
CY2021	NCRA	Proceeds From Common Stock And Warrant Issuance ProceedsFromCommonStockAndWarrantIssuance	120000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5666124	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2090000	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2820	usd
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
CY2022	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	619447	usd
CY2021	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	0	usd
CY2022	us-gaap	Repayments Of Subordinated Short Term Debt RepaymentsOfSubordinatedShortTermDebt	-0	usd
CY2021	us-gaap	Repayments Of Subordinated Short Term Debt RepaymentsOfSubordinatedShortTermDebt	487826	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6288391	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1203833	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115485	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-10017	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	462065	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1420478	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2444009	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1023531	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2906074	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2444009	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-7900000	usd
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zCcPGCjGz7ol" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_86E_zGJ9UOCWsoll">Reclassification</span> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain prior period amounts have been reclassified to conform with current year presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022	NCRA	Foreign Currency Exchange Rate Translation2 ForeignCurrencyExchangeRateTranslation2	6.7208	pure
CY2021	NCRA	Foreign Currency Exchange Rate Translation2 ForeignCurrencyExchangeRateTranslation2	6.3700	pure
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_z4WYVdgv5eT8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_861_z5jh4dFFllGb">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the allowance for doubtful receivables; the useful lives of property and equipment and intangible assets; impairment of long-lived assets; recoverability of the carrying amount of inventory; fair value of financial instruments; provisional amounts based on reasonable estimates for certain income tax effects of the Tax Act and the assessment of deferred tax assets or liabilities. These estimates are often based on complex judgments and assumptions that management believes to be reasonable but are inherently uncertain and unpredictable. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zeVORH8JTQL4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_864_zhw8iBNhv4w6">Concentrations of Credit Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its customers and suppliers, and generally does not require collateral or other security from them. The Company evaluates its collection experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There was four customers who represented <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zxxf21zSdw6a" title="Concentration risk">49.62</span>% of the Company's total revenue during the years ended December 31, 2022. There was one customer who represented <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zZ0nmXRj4WD3" title="Concentration risk">58.22</span>% of the Company's total revenue during the years ended December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth a summary of single customers who represent 10% or more of the Company’s total accounts receivable, net:</p> <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zrAQyHngkb34" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)"> <tr style="vertical-align: bottom"> <td> <span id="xdx_8B6_zVdUwRa5EGdc" style="display: none">Concentrations of credit risk</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Percentage of the Company’s accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: justify">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zuRtjwwHMHd2" title="Concentration percentage">50.83</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zLVdwbPQlEt3" title="Concentration percentage">16.37</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zK7InucM6u3e" title="Concentration percentage">14.73</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp0_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z4gEBUIeGwB6" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zJBaY7W6QLq4" title="Concentration percentage">31.82</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp0_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zDIILGHzHXei" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Customer D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_zg1zJYKdlErl" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember_z7eWPiSTFrW2" title="Concentration percentage">59.53</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Customer E</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zgabkBzeeEp1" title="Concentration percentage">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember_zID6zWU4kvc6" title="Concentration percentage">16.30</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_zKhmfPqgauIe" title="Concentration percentage">97.38</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_zwg7wHBEmvSa" title="Concentration percentage">92.20</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The following table sets forth a summary of single suppliers who represent 10% or more of the Company’s total purchase:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Percentage of the Company’s purchase</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: justify">Supplier A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierAMember_zvN6ZwTuDL4i" title="Concentration percentage">–</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierAMember_z4mYNxrMg2K8" title="Concentration percentage">48.76</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zRz5bCZi23M" title="Concentration percentage">18.60</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zzPh5c99l51i" title="Concentration percentage">15.14</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Supplier C</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp0_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_zZWw2GO3J0Ne" title="Concentration percentage">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_z7Vo7G3f8PPh" title="Concentration percentage">14.26</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllSuppliersMember_zm2MehBNn3qk" title="Concentration percentage">18.60</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllSuppliersMember_zTR0X3DbPph3" title="Concentration percentage">78.16</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zKLAuJViAfca" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	0	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	0	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	0	usd
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	0	usd
CY2022Q4	us-gaap	Cash Cash	2906074	usd
CY2021Q4	us-gaap	Cash Cash	2444009	usd
CY2022Q4	NCRA	Finite Lived Intangible Assets Translation Adjustments FiniteLivedIntangibleAssetsTranslationAdjustments	0	usd
CY2021Q4	NCRA	Finite Lived Intangible Assets Translation Adjustments FiniteLivedIntangibleAssetsTranslationAdjustments	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4891	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-0	usd
CY2022Q4	NCRA	Accumulated Impairment Of Intangible Assets Excluding Goodwill AccumulatedImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2021Q4	NCRA	Accumulated Impairment Of Intangible Assets Excluding Goodwill AccumulatedImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	130434	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	usd
CY2022Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	214913	usd
CY2022Q4	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	6.9646	pure
CY2021Q4	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	6.4854	pure
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	209777	usd
CY2021Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	699555	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	209777	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	699555	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2021Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	0	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	91781	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	97163	usd
CY2022Q4	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	0	usd
CY2021Q4	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	1391518	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	91781	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1488681	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	1732	usd
CY2021Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	42969	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27470	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	107444	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	903867	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	78802	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	59254	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7557	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	844613	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	71245	usd
CY2022	us-gaap	Depreciation Depreciation	66907	usd
CY2021	us-gaap	Depreciation Depreciation	6127	usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2021Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	3905735	usd
CY2021Q4	us-gaap	Goodwill Goodwill	332040	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	135325	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	0	usd
CY2022Q4	us-gaap	Other Loans Payable OtherLoansPayable	651254	usd
CY2021Q4	us-gaap	Other Loans Payable OtherLoansPayable	0	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	312320	usd
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	usd
CY2022	NCRA	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings1	0	usd
CY2021	NCRA	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings1	24800	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1179768	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	312320	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	51227	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	4424	usd
CY2022	us-gaap	Lease Cost LeaseCost	51227	usd
CY2021	us-gaap	Lease Cost LeaseCost	4424	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	0	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	40023	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	861	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	89775	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	37527	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	12628	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	38388	usd
CY2021Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	142426	usd
CY2021Q4	NCRA	Value Added Tax Rate ValueAddedTaxRate	0.16	pure
CY2022Q4	NCRA	Value Added Tax Rate ValueAddedTaxRate	0.13	pure
CY2022	NCRA	Global Intangible Low Taxed Income GlobalIntangibleLowTaxedIncome	152829	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	23808	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-139932	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-23808	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	139932	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	0.2000	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	0.2000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.1348	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.0678	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.0869	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.1471	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0254	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0001	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0107	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.0012	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0049	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0101	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0001	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0143	pure
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	23391	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	23391	usd
CY2022Q4	NCRA	Deferred Tax Assets Valuation Allowance Currents DeferredTaxAssetsValuationAllowanceCurrents	0	usd
CY2021Q4	NCRA	Deferred Tax Assets Valuation Allowance Currents DeferredTaxAssetsValuationAllowanceCurrents	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	23391	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	95844	usd
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	95844	usd
CY2022	NCRA	Valuation Allowance Deferred Tax Asset Change In Amount1 ValuationAllowanceDeferredTaxAssetChangeInAmount1	0	usd
CY2021	NCRA	Valuation Allowance Deferred Tax Asset Change In Amount1 ValuationAllowanceDeferredTaxAssetChangeInAmount1	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	95844	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	95844	usd
CY2021Q4	NCRA	Due From A Related Party DueFromARelatedParty	1615217	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	2:3 reverse stock split
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10707150	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7138587	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9243587	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7071920	shares
CY2020Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.50
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.50
CY2022Q4	us-gaap	Contractual Obligation ContractualObligation	0	usd
CY2021Q4	us-gaap	Contractual Obligation ContractualObligation	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0116	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0116	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y3M21D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y3M21D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.4815	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.4815	pure
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	11114097	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y11M26D
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.00
CY2021Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.50
CY2022Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	2:3 reverse stock split
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4812908	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9619079	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7876367	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6107727	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7876367	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6107727	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.6111
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.0757
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.6111
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-1.0757

Files In Submission

Name	View Source	Status
ncra-20221231_def.xml	Edgar Link	unprocessable
ncra-20221231_pre.xml	Edgar Link	unprocessable
ncra-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ncra-20221231_cal.xml	Edgar Link	unprocessable
0001683168-23-002043-index-headers.html	Edgar Link	pending
0001683168-23-002043-index.html	Edgar Link	pending
0001683168-23-002043.txt	Edgar Link	pending
0001683168-23-002043-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
n1.jpg	Edgar Link	pending
ncra-20221231.xsd	Edgar Link	pending
nocera_ex2101.htm	Edgar Link	pending
nocera_ex3101.htm	Edgar Link	pending
nocera_ex3102.htm	Edgar Link	pending
nocera_ex3201.htm	Edgar Link	pending
nocera_ex3202.htm	Edgar Link	pending
nocera_i10k-123122.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
nocera_i10k-123122_htm.xml	Edgar Link	completed
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NCRA
NOCERA, INC. Stock $ncra

2023 Q1 Form 10-K Financial Statement

#000168316823002043 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NCRA NOCERA, INC. Stock $ncra

2023 Q1 Form 10-K Financial Statement

#000168316823002043 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NCRA
NOCERA, INC. Stock $ncra